Agence France-Presse

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

Masimo (NASDAQ: MASI) today announced the findings of an exploratory analysis for a unique feasibility study published in ...